Suppliers / Kaifeng Pharmaceutical (Group)

Kaifeng Pharmaceutical (Group)

China Updated 9 July 2026

Kaifeng Pharmaceutical (Group) is an API manufacturer based in China. It holds one active US drug master file and 2 valid CEPs across a filed portfolio of 2 molecules.

1
active US DMFs
2
valid CEPs
1
registered plants
2
filings across 1 regulators

Registered plants

Site FDA FEI
Kaifeng, China Not on file

What they file, and where

Molecule Regulators Docs
Doxycycline EDQM 2
Obeticholic Acid US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 2 None

Questions about Kaifeng Pharmaceutical (Group)

Does Kaifeng Pharmaceutical (Group) hold a US DMF or a CEP?
Kaifeng Pharmaceutical (Group) holds 1 active US drug master file and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Kaifeng Pharmaceutical (Group) manufacture?
1 registered site is on record, in China (Kaifeng). Every site is listed on this page with the register it came from.
What does Kaifeng Pharmaceutical (Group) make?
2 molecules are on record against Kaifeng Pharmaceutical (Group), including Doxycycline and Obeticholic Acid. Each links through to that molecule's full manufacturer list.
Where does Kaifeng Pharmaceutical (Group) file?
Filings are on record with DAV (Vietnam), 2 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Kaifeng Pharmaceutical (Group) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability